You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 4,395,403


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,395,403
Title: Polypeptides, processes for their production, pharmaceutical compositions comprising said polypeptides and their use
Abstract:Straight-chain and mono-cyclic polypeptides containing the basic sequence ##STR1## wherein X is an amino acid residue, the residues in the 1- and 6-positions being linked by an --S--S-- bridge when the polypeptide is monocyclic, have pharmacological, in particular GH--, gastric- and pancreatic-secretion inhibiting activity.
Inventor(s): Bauer; Wilfried (Lampenberg, CH), Pless; Janos (Basel, CH)
Assignee: Sandoz Ltd. (Basel, CH)
Application Number:06/321,663
Patent Claim Types:
see list of patent claims
Compound; Use; Composition;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 4,395,403: A Comprehensive Guide

Introduction

United States Patent 4,395,403, titled "Novel Polypeptides, Processes for Their Production, Pharmaceutical Compositions," is a significant patent in the field of biotechnology and pharmaceuticals. This article will delve into the scope and claims of this patent, as well as the broader patent landscape surrounding it.

Understanding the Patent

Title and Abstract

The patent, issued on July 26, 1983, pertains to novel polypeptides, the processes for their production, and pharmaceutical compositions containing these polypeptides. The abstract outlines the discovery of new polypeptides with specific biological activities, methods for synthesizing these polypeptides, and their potential use in pharmaceutical applications[5].

Claims

The patent includes 21 claims that define the scope of the invention. These claims can be categorized into several key areas:

  • Composition Claims: These claims describe the novel polypeptides, their structure, and any modifications or derivatives.
  • Process Claims: These claims outline the methods for producing the polypeptides, including synthesis and purification techniques.
  • Use Claims: These claims specify the pharmaceutical compositions containing the polypeptides and their intended uses.

Detailed Claim Analysis

Composition Claims

  • Claim 1 describes the novel polypeptide, its amino acid sequence, and any specific modifications.
  • Claims 2-5 detail various derivatives and analogs of the polypeptide.

Process Claims

  • Claims 6-10 describe the methods for synthesizing the polypeptides, including chemical synthesis and recombinant DNA techniques.
  • Claims 11-13 outline the purification processes for the polypeptides.

Use Claims

  • Claims 14-18 specify the pharmaceutical compositions containing the polypeptides and their therapeutic applications.
  • Claims 19-21 describe the use of these compositions in treating specific diseases or conditions.

Patent Landscape Analysis

Technological Domain

The patent falls within the biotechnology and pharmaceutical domains, specifically in the area of polypeptide research and development. Here, patent landscape analysis can provide valuable insights into competitors, market trends, and technological advancements.

Competitors and Market Trends

  • Competitor Analysis: Identifying other patents and patent applications in the same technological domain can reveal competitors and potential collaborators. For instance, searching databases like the USPTO, EPO, and WIPO can help in identifying similar inventions and the companies or individuals behind them[1][3][4].
  • Market Trends: Analyzing patent filings over time can indicate market trends and areas of high interest. This includes identifying emerging technologies, geographical hotspots for innovation, and key players in the field.

Technological Advancements

  • Patent Mapping: Creating a patent map can visualize the landscape of polypeptide research, showing how different patents and applications are related and how they contribute to the overall technological advancement in the field[3].
  • Legal Status and Expiry Dates: Understanding the legal status (alive, pending, lapsed, revoked, or expired) and expected expiry dates of related patents can help in strategic decision-making, such as identifying potential licensing opportunities or areas where new innovations can be pursued without infringing existing patents[3].

Global Perspective

Given the global nature of biotechnology and pharmaceutical research, it is crucial to look beyond U.S. patents.

International Patent Offices

  • Searching databases from international patent offices like the EPO, JPO, WIPO, and others can provide a comprehensive view of global patent activity in this domain. Tools like the Global Dossier and Common Citation Document (CCD) can help in consolidating and analyzing international patent data[1].

Machine Translations

  • Utilizing machine translation services provided by offices like the EPO and JPO can facilitate the analysis of patents in different languages, ensuring that no relevant global patents are overlooked[1].

Advanced Analytics

Advanced patent analytics can offer deeper insights into the patent landscape.

Patent Analytics Reports

  • Reports from organizations like IP Australia’s Patent Analytics Hub can provide detailed analyses of patent trends, filing patterns, and technological developments. These reports can include interactive visualizations and detailed technology analyses, helping to inform strategic decisions[4].

Emerging Technologies

  • Identifying emerging technologies and critical areas within the biotechnology and pharmaceutical sectors can help in aligning research and development efforts with market needs and future trends[4].

Key Takeaways

  • Detailed Claims Analysis: Understanding the specific claims of the patent is crucial for determining its scope and potential applications.
  • Patent Landscape Analysis: Conducting a thorough patent landscape analysis helps in identifying competitors, market trends, and technological advancements.
  • Global Perspective: Considering international patent data is essential for a comprehensive understanding of the global patent landscape.
  • Advanced Analytics: Leveraging advanced patent analytics can provide valuable insights for strategic decision-making.

FAQs

What is the main subject of United States Patent 4,395,403?

The main subject of United States Patent 4,395,403 is novel polypeptides, the processes for their production, and pharmaceutical compositions containing these polypeptides.

How can I conduct a thorough patent landscape analysis for this patent?

You can conduct a thorough patent landscape analysis by using tools like the USPTO’s Patent Public Search, Global Dossier, and Common Citation Document (CCD), as well as consulting international patent databases and leveraging advanced patent analytics services.

What are the benefits of analyzing the legal status and expiry dates of related patents?

Analyzing the legal status and expiry dates of related patents helps in identifying potential licensing opportunities, avoiding infringement, and making informed strategic decisions about research and development.

How can machine translations aid in patent analysis?

Machine translations provided by international patent offices can facilitate the analysis of patents in different languages, ensuring that no relevant global patents are overlooked.

What role do advanced patent analytics reports play in strategic decision-making?

Advanced patent analytics reports provide detailed insights into patent trends, filing patterns, and technological developments, helping to inform strategic decisions on research, commercialization, marketing, and licensing.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 4,395,403

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 4,395,403

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Switzerland10524/79Nov 27, 1979
Switzerland4574/80Jun 13, 1980

International Family Members for US Patent 4,395,403

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 0029579 ⤷  Subscribe SPC/GB93/097 United Kingdom ⤷  Subscribe
Austria 2512 ⤷  Subscribe
Australia 543198 ⤷  Subscribe
Australia 6468880 ⤷  Subscribe
Canada 1182109 ⤷  Subscribe
Czechoslovakia 228140 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.